Related Experiment Video
Updated: Mar 26, 2026

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
Marfanoid-progeroid-lipodystrophy syndrome: a newly recognized fibrillinopathy
Eberhard Passarge1,2, Peter N Robinson3, Luitgard M Graul-Neumann4
1Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany.
Abstract:
We review six previous reports between 2000 and 2014 of seven unrelated patients with mutations in the FBN1 gene affecting function. All mutations occurred in exon 64 of the FBN1 gene. A distinctive phenotype consisting of partial manifestations of Marfan syndrome, a progeroid facial appearance, and clinical features of lipodystrophy was present in all individuals. We suggest that this previously unknown genotype/phenotype relationship constitutes a new fibrillinopathy for which the name marfanoid-progeroid-lipodystrophy syndrome would be appropriate.
Insights
Researchers identified a new genetic disorder, marfanoid-progeroid-lipodystrophy syndrome, linked to FBN1 gene mutations. This condition presents with Marfan syndrome features, a progeroid appearance, and lipodystrophy.
Area of Science:
- Genetics
- Molecular Biology
- Medical Genetics
Background:
- Marfan syndrome is a genetic disorder affecting connective tissue, primarily due to mutations in the FBN1 gene.
- Previous reports have documented various FBN1 gene mutations and their associated phenotypes.
- Lipodystrophy and progeroid facial appearance are distinct conditions that can occur independently.
Purpose of the Study:
- To investigate a potential novel genotype/phenotype relationship associated with FBN1 gene mutations.
- To characterize a distinct clinical syndrome observed in patients with specific FBN1 mutations.
- To propose a new classification for this newly identified fibrillinopathy.
Main Methods:
- Literature review of six previous reports (2000-2014) concerning seven unrelated patients.
- Analysis of genetic data focusing on mutations within the FBN1 gene.
- Clinical phenotyping of affected individuals, noting shared characteristics.
Main Results:
- All seven patients shared mutations in exon 64 of the FBN1 gene.
- A consistent phenotype was observed, including partial Marfan syndrome features.
- Patients also exhibited a progeroid facial appearance and clinical signs of lipodystrophy.
Conclusions:
- The identified genotype/phenotype correlation suggests a new fibrillinopathy.
- The distinct clinical presentation warrants recognition as a unique syndrome.
- The proposed name, marfanoid-progeroid-lipodystrophy syndrome, accurately reflects the observed characteristics.
More Related Videos
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Cytoskeletal Linker Proteins - Plakins

